MBMontserrat Bonfill-Ortí

Montserrat Bonfill-Ortí

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Montserrat Bonfill-Ortí has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities

    by Irene García-Jiménez, Ignasi Figueras-Nart, Lídia Sans-De San Nicolás, Laia Curto-Barredo, Marta Bertolín-Colilla, Montserrat Bonfill-Ortí, Sandra Díez-Ribas, Alex Llobet-Del Pino, Antonio Guilabert-Vidal, Anna Ryzhkova, et al.

    Lactate dehydrogenase (LDH) is a serum biomarker well known to correlate with disease severity in atopic dermatitis (AD). The aim of this study was to explore the cutaneous immune responses and the clinical profile of AD patients in relation to serum LDH levels. To this end, 47 untreated, adult patients with moderate-to-severe AD were stratified by median levels of serum LDH. Circulating memory T-cell responses to house dust mite (HDM) extract, in the presence of autologous lesional epidermal cells, were compared between AD subgroups. The LDHhigh group exhibited significantly higher IL-13, IL-5 and IL-9 in vitro responses confined to the cutaneous lymphocyte-associated antigen (CLA)+ subset compared to LDHlow patients. Clinically, LDHhigh patients were younger and exhibited more severe disease, elevated eosinophil counts in their blood, increased total and specific IgE levels in their plasma, and a higher prevalence of allergic rhinitis. Our data suggests that high LDH levels identify a subgroup of AD patients with a specific immune and clinical profile, and highlight the potential of LDH as a clinical parameter that may enable patient stratification for treatment selection.


  • Open Access

    Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients

    by Irene García-Jiménez, Lídia Sans-De San Nicolás, Laia Curto-Barredo, Marta Bertolín-Colilla, Eloi Sensada-López, Ignasi Figueras-Nart, Montserrat Bonfill-Ortí, Antonio Guilabert-Vidal, Anna Ryzhkova, Marta Ferran, et al.

    Interleukin (IL)-9 is present in atopic dermatitis (AD) lesions and is considered to be mainly produced by skin-homing T cells expressing the cutaneous lymphocyte-associated antigen (CLA). However, its induction by AD-associated triggers remains unexplored. Circulating skin-tropic CLA+ and extracutaneous/systemic CLA− memory T cells cocultured with autologous lesional epidermal cells from AD patients were activated with house dust mite (HDM) and staphylococcal enterotoxin B (SEB). Levels of AD-related mediators in response to both stimuli were measured in supernatants, and the cytokine response was associated with different clinical characteristics. Both HDM and SEB triggered heterogeneous IL-9 production by CLA+ and CLA− T cells in a clinically homogenous group of AD patients, which enabled patient stratification into IL-9 producers and non-producers, with the former group exhibiting heightened HDM-specific and total IgE levels. Upon allergen exposure, IL-9 production depended on the contribution of epidermal cells and class II-mediated presentation; it was the greatest cytokine produced and correlated with HDM-specific IgE levels, whereas SEB mildly induced its release. This study demonstrates that both skin-tropic and extracutaneous memory T cells produce IL-9 and suggests that the degree of allergen sensitization reflects the varied IL-9 responses in vitro, which may allow for patient stratification in a clinically homogenous population.


  • Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients

    by H. Escolà, I. Figueras‐Nart, M. Bonfill‐Orti, N. Coll Puigserver, A. Martin‐Santiago, M. Rodríguez Serna, M. C. Sánchez Hernández, J. L. Sanz‐Cabanillas, R. Taberner, V. Zaragoza‐Ninet, et al.


  • ESDR053 - SEB-induced IL-13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis

    by Lídia Sans-De San Nicolàs, Ignasi Figueras-Nart, Montserrat Bonfill-Ortí, Irene García-Jiménez, Antonio Guilabert-Vidal, Laia Curto-Barredo, Marta Ferran, Esther Serra-Baldrich, Ramon M. Pujol, Luis F Santamaria-Babí

    There is currently no clear in vitro model to study the Th2 status in atopic dermatitis (AD). Staphylococcus aureus, skin-homing cutaneous lympho | POSTER